generics
Cephalon completes acquisition of generics firm Mepha
April 16, 2010Sales and Marketing Cephalon, generics
Specialist pharmaceutical company Cephalon has completed the $615.4 million acquisition of Mepha. Based in Switzerland, Mepha specialises in using reformulation …
GSK agrees generic deal on Malarone
April 13, 2010Sales and Marketing GSK, depression, generics
Generic versions of two GlaxoSmithKline products have received the green light for launch in the US. Mylan has been given …
Merck to be hit by Cozaar generics
April 9, 2010Merck, Teva, generics
Generic versions of Merck’s hypertension treatments Cozaar and Hyzaar are to be launched in the US for the first time. …
Generic substitution will not deliver significant NHS savings, says EMIG
March 31, 2010Sales and Marketing EMIG, NHS, generics
The Department of Health’s plans for automatic generic substitution will not result in significant savings for the NHS and should …
GSK breathes more easily after Sandoz exit
March 24, 2010Sales and Marketing Advair, Sandoz, generics, vectura
Sandoz has exited a deal to launch a generic rival to GSK’s top selling respiratory drug Advair. Sandoz, the generics …
AstraZeneca signs generics deal with Torrent
March 11, 2010AZ, generics
AstraZeneca have signed a license and supply agreement with Indian-based Torrent Pharma that will boost its generics portfolio. Torrent will …
Pfizer muscles in on Ratiopharm sale
March 11, 2010Sales and Marketing Pfizer, Ratiopharm, Teva, generics
Pfizer has reportedly bid $4 billion for German generics firm Ratiopharm in a bid to rapidly expands its portfolio in …
Brennan rejects generics diversification model
February 11, 2010Sales and Marketing AstraZeneca, biosimilars, em, generics, industry
AstraZeneca’s chief executive David Brennan has rejected the strategy of diversification into generics and biosimilars being pursued by many of …
Actavis looks internally and externally for growth
February 10, 2010Manufacturing and Production Actavis, generics
Actavis is planning to increase the size of its manufacturing site in Iceland in order to boost output to around …
Generics firm press for ‘clear and open’ market
February 8, 2010Sales and Marketing generics, industry
Generic drug companies have set out their vision of a more ‘clear’ and ‘open’ market in Europe. Greg Perry, director …
US generics company expands into Eastern Europe
January 19, 2010Sales and Marketing Alvogen, Eastern Europe, generics
US generics company Alvogen has announced an ambitious expansion into the lucrative markets of Eastern Europe. The company has opened …
Commission probes Lundbeck on alleged generic blocking
January 18, 2010Sales and Marketing European Commission, Lundbeck, generics, kroes
The European Commission has confirmed it is to investigate Lundbeck for alleged anti-competitive behaviour relating to its anti-depressant Cipramil. The …
England moves forward on generic substitution
January 8, 2010Sales and Marketing NHS, generics, substitution
The UK Department of Health has started a consultation on proposals that would allow generic medicines to be substituted for …
Pharma mergers and acquisitions in 2009
December 22, 2009Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review
This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
Commission launches new wave of anti-trust raids
December 15, 2009Sales and Marketing Europe, European Commission, Lundbeck, Teva, generics, kroes
The European Commission has launched a new series of raids on pharmaceutical companies as part of its crackdown on alleged …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
